Detalhe da pesquisa
1.
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohort.
Breast Cancer Res Treat
; 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38703285
2.
Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study.
Breast Cancer Res Treat
; 203(1): 163-172, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773555
3.
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
Breast Cancer Res Treat
; 201(2): 151-159, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338729
4.
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol
; 23(1): 149-160, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902335
5.
How we treat HR-positive, HER2-negative early breast cancer.
Future Oncol
; 18(8): 1003-1022, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094535
6.
The importance of physical exercise in cardiovascular fitness in breast cancer survivors. A cross-sectional study: women in Motion 2.0.
Support Care Cancer
; 30(8): 6745-6754, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524144
7.
A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH): study protocol.
BMC Psychiatry
; 22(1): 817, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36544126
8.
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.
Lancet Oncol
; 19(6): 812-824, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29706375
9.
Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit.
J Genet Couns
; 27(4): 854-862, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247312
10.
Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer.
Breast Cancer Res Treat
; 162(1): 181-189, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28040858
11.
Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer.
Future Oncol
; 13(24): 2137-2149, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28758424
12.
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
Breast Cancer Res Treat
; 156(3): 507-515, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27083178
13.
Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial.
Breast Cancer Res Treat
; 153(2): 371-82, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26293147
14.
Evaluation of a heredofamilial cancer unit in increasing family history collection and genetic counseling referrals among Spanish oncologists at a university hospital.
J Genet Couns
; 23(1): 108-13, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23771728
15.
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy.
Clin Cancer Res
; 30(10): 2160-2169, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466643
16.
Circulating tumor cells following first chemotherapy cycle: an early and strong predictor of outcome in patients with metastatic breast cancer.
Oncologist
; 18(8): 917-23, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23873719
17.
Impact of the COVID-19 Lockdown on Physical Activity Levels and Health Parameters in Young Adults with Cancer.
Curr Oncol
; 30(6): 5395-5408, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366892
18.
Laser transfer for circulating tumor cell isolation in liquid biopsy.
Int J Bioprint
; 9(4): 720, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37323505
19.
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab.
JAMA Oncol
; 9(6): 841-846, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37103916
20.
Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies.
Breast Cancer Res Treat
; 134(2): 583-93, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22644656